Chapter 1. NGS Diagnostics For Rare Diseases Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
 Chapter 2. NGS Diagnostics For Rare Diseases Market – Executive Summary
2.1    Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
             2.2.1    Demand Side
             2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis
 Chapter 3. NGS Diagnostics For Rare Diseases Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis
 Chapter 4. NGS Diagnostics For Rare Diseases Market - Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
             4.5.1    Bargaining Power of Suppliers
             4.5.2    Bargaining Powers of Customers
             4.5.3    Threat of New Entrants
             4.5.4    Rivalry among Existing Players
             4.5.5    Threat of Substitutes
 Chapter 5. NGS Diagnostics For Rare Diseases Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities
 Chapter 6. NGS Diagnostics For Rare Diseases Market – By Disease Type Outlook
6.1    Introduction/Key Findings   
6.2    Neurological Disease 
6.3    Immunological Disorders
6.4    Hematology Diseases
6.5    Endocrine & Metabolism Diseases
6.6    Cancer
6.7    Musculoskeletal Disorders
6.8    Cardiovascular Disorders (CVDs)
6.9    Others
6.10    Y-O-Y Growth trend Analysis By Disease Type Outlook
6.11    Absolute $ Opportunity Analysis By Disease Type Outlook, 2024-2030
 Chapter 7. NGS Diagnostics For Rare Diseases Market – By Specialty Outlook
7.1    Introduction/Key Findings  
7.2    Molecular Genetic Tests 
7.3    Chromosomal Genetic Tests
7.4    Biochemical Genetic Tests 
7.5    Others
7.6    Y-O-Y Growth  trend Analysis By Specialty Outlook
7.7    Absolute $ Opportunity Analysis By Specialty Outlook, 2024-2030
 Chapter 8. NGS Diagnostics For Rare Diseases Market –  By End-Use Outlook
8.1    Introduction/Key Findings
8.2    Research Laboratories & CROs
8.3    Hospitals & Clinics
8.4    Diagnostic Laboratories
8.5    Y-O-Y Growth trend Analysis By End-Use Outlook
8.6    Absolute $ Opportunity Analysis By End-Use Outlook, 2024-2030
 Chapter 9. NGS Diagnostics For Rare Diseases Market , By Geography – Market Size, Forecast, Trends & Insights
9.1    North America
             9.1.1    By Country
                          9.1.1.1    U.S.A.
                          9.1.1.2    Canada
                          9.1.1.3    Mexico
             9.1.2    By Specialty Outlook
             9.1.3    By End-Use Outlook
             9.1.4    By Disease Type Outlook
             9.1.5    Countries & Segments - Market Attractiveness Analysis
9.2    Europe
             9.2.1    By Country
                          9.2.1.1    U.K
                          9.2.1.2    Germany
                          9.2.1.3    France
                          9.2.1.4    Italy
                          9.2.1.5    Spain
                          9.2.1.6    Rest of Europe
             9.2.2    By Specialty Outlook
             9.2.3    By End-Use Outlook
             9.2.4    By Disease Type Outlook
             9.2.5    Countries & Segments - Market Attractiveness Analysis
9.3    Asia Pacific
             9.3.1    By Country
                          9.3.1.1    China
                          9.3.1.2    Japan
                          9.3.1.3    South Korea
                          9.3.1.4    India      
                          9.3.1.5    Australia & New Zealand
                          9.3.1.6    Rest of Asia-Pacific
             9.3.2    By Specialty Outlook
             9.3.3    By End-Use Outlook
             9.3.4    By Disease Type Outlook
             9.3.5    Countries & Segments - Market Attractiveness Analysis
9.4    South America
             9.4.1    By Country
                          9.4.1.1    Brazil
                          9.4.1.2    Argentina
                          9.4.1.3    Colombia
                          9.4.1.4    Chile
                          9.4.1.5    Rest of South America
             9.4.2    By Specialty Outlook
             9.4.3    By End-Use Outlook
             9.4.4    By Disease Type Outlook
             9.4.5    Countries & Segments - Market Attractiveness Analysis
9.5    Middle East & Africa
             9.5.1    By Country
                          9.5.1.1    United Arab Emirates (UAE)
                          9.5.1.2    Saudi Arabia
                          9.5.1.3    Qatar
                          9.5.1.4    Israel
                          9.5.1.5    South Africa
                          9.5.1.6    Nigeria
                          9.5.1.7    Kenya
                          9.5.1.8    Egypt
                          9.5.1.9    Rest of MEA
             9.5.2    By Specialty Outlook
             9.5.3    By End-Use Outlook
             9.5.4    By Disease Type Outlook
             9.5.5    Countries & Segments - Market Attractiveness Analysis
 Chapter 10. NGS Diagnostics For Rare Diseases Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
10.1    Quest Diagnostics Inc.
10.2    Centogene N.V.
10.3    Invitae Corp.
10.4    3billion, Inc.
10.5    Arup Laboratories
10.6    Eurofins Scientific
10.7    Strand Life Sciences
10.8    Ambry Genetics
10.9    Perkin Elmer, Inc.
10.10    Macrogen, Inc.